Related Experiment Video
Updated: May 8, 2026

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
YAP1 preserves tubular mitochondrial quality control to mitigate diabetic kidney disease
Siyang Ye1, Meng Zhang1, Xunhua Zheng1
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China; NHC Key Laboratory of Clinical Nephrology (Sun Yat-sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, 510080, China.
Abstract:
Renal tubule cells act as a primary site of injury in diabetic kidney disease (DKD), with dysfunctional mitochondrial quality control (MQC) closely associated with progressive kidney dysfunction in this context. Our investigation delves into the observed inactivation of yes-associated protein 1 (YAP1) and consequential dysregulation of MQC within renal tubule cells among DKD subjects through bioinformatic analysis of transcriptomics data from the Gene Expression Omnibus (GEO) dataset. Receiver operating characteristic curve analysis unequivocally underscores the robust diagnostic accuracy of YAP1 and MQC-related genes for DKD. Furthermore, we observed YAP1 inactivation, accompanied by perturbed MQC, within cultured tubule cells exposed to high glucose (HG) and palmitic acid (PA). This pattern was also evident in the tubulointerstitial compartment of kidney sections from biopsy-approved DKD patients. Additionally, renal tubule cell-specific Yap1 deletion exacerbated kidney injury in diabetic mice. Mechanistically, Yap1 deletion disrupted MQC, leading to mitochondrial aberrations in mitobiogenesis and mitophagy within tubule cells, ultimately culminating in histologic tubular injury. Notably, Yap1 deletion-induced renal tubule injury promoted the secretion of C-X-C motif chemokine ligand 1 (CXCL1), potentially augmenting M1 macrophage infiltration within the renal microenvironment. These multifaceted events were significantly ameliorated by administrating the YAP1 activator XMU-MP-1 in DKD mice. Consistently, bioinformatic analysis of transcriptomics data from the GEO dataset revealed a noteworthy upregulation of tubule cells-derived chemokine CXCL1 associated with macrophage infiltration among DKD patients. Crucially, overexpression of YAP1 via adenovirus transfection sustained mitochondrial membrane potential, mtDNA copy number, oxygen consumption rate, and activity of mitochondrial respiratory chain complex, but attenuated mitochondrial ROS production, thereby maintaining MQC and subsequently suppressing CXCL1 generation within cultured tubule cells exposed to HG and PA. Collectively, our study establishes a pivotal role of tubule YAP1 inactivation-mediated MQC dysfunction in driving DKD progression, at least in part, facilitated by promoting M1 macrophage polarization through a paracrine-dependent mechanism.
Insights
In diabetic kidney disease (DKD), inactivated yes-associated protein 1 (YAP1) disrupts mitochondrial quality control (MQC) in kidney tubule cells, worsening injury. Restoring YAP1 function ameliorates DKD progression and kidney damage.
Area of Science:
- Nephrology
- Molecular Biology
- Mitochondrial Biology
Background:
- Diabetic kidney disease (DKD) involves renal tubule cell injury and mitochondrial dysfunction.
- Mitochondrial quality control (MQC) is crucial for maintaining cellular health in renal tubules.
- Dysfunctional MQC is linked to progressive kidney dysfunction in DKD.
Purpose of the Study:
- To investigate the role of yes-associated protein 1 (YAP1) inactivation in MQC dysregulation within renal tubule cells in DKD.
- To explore the diagnostic potential of YAP1 and MQC-related genes in DKD.
- To elucidate the mechanisms by which YAP1 influences MQC and kidney injury in DKD.
Main Methods:
- Bioinformatic analysis of Gene Expression Omnibus (GEO) transcriptomics data.
- Receiver operating characteristic (ROC) curve analysis.
- In vitro studies using cultured renal tubule cells exposed to high glucose and palmitic acid.
- In vivo studies using diabetic mouse models with targeted Yap1 deletion or YAP1 activator administration.
- Analysis of kidney biopsy samples from DKD patients.
Main Results:
- YAP1 inactivation and MQC dysregulation were observed in DKD subjects, cultured cells, and patient kidney tissues.
- YAP1 and MQC genes showed high diagnostic accuracy for DKD.
- Renal tubule-specific Yap1 deletion exacerbated kidney injury, disrupted MQC, and increased C-X-C motif chemokine ligand 1 (CXCL1) secretion.
- YAP1 activation ameliorated DKD progression and reduced CXCL1 secretion in mice.
- YAP1 overexpression in vitro maintained mitochondrial function and suppressed CXCL1 production.
Conclusions:
- Tubule YAP1 inactivation is a key driver of MQC dysfunction in DKD progression.
- YAP1 inactivation promotes M1 macrophage polarization via CXCL1, contributing to kidney injury.
- Targeting YAP1 represents a potential therapeutic strategy for DKD.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025